Riskpilot← Back to searchSign inGet full accessBomedica AB
ABActiveOrg 5591587539Drottninggatan 37 Läg 2102General medical practice activities · NACE 8621Est. 20180 employees
Revenue 2025
SEK 123K
-33% vs 2024
EBITDA margin
77.8%
-34% vs 2024
Equity ratio
72.8%
Financial strength
Net profit 2025
SEK 76K
-33% vs 2024
| Revenue | SEK 123K | -33% |
| EBITDA | SEK 95K | -34% |
| Net profit | SEK 76K | -33% |
| Total assets | SEK 183K | -27% |
| Equity | SEK 133K | -20% |
| Employees | 0 | — |
Legal name
Bomedica AB
Org number
5591587539
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 maj 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk konsultverksamhet och uthyrning av medicinsk personal, äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Drottninggatan 37 Läg 2102
Email
bossealkestrand@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 140 | 144 | 150 | 184 | 123 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 104 | 115 | 111 | 144 | 95 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 104 | 115 | 111 | 144 | 95 |
| Net financials | −1 | −7 | −0 | 1 | 1 |
| Profit before tax | 103 | 108 | 111 | 144 | 96 |
| Tax | −22 | −24 | −23 | −30 | −20 |
| Net profit | 81 | 84 | 88 | 115 | 76 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 222 | 198 | 191 | 251 | 183 |
| Equity | 132 | 134 | 142 | 167 | 133 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 90 | 64 | 49 | 84 | 50 |
| Total debt | 90 | 64 | 49 | 84 | 50 |
EBITDA margin
77.8%
This company
15.8%
Market median
+392% vs market
20212025
Equity ratio
72.8%
This company
38.2%
Market median
+91% vs market
20212025
Return on equity
57.3%
This company
18.4%
Market median
+211% vs market
20212025
Net profit margin
62.3%
This company
8.1%
Market median
+669% vs market
20212025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20212025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KH Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bomedica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Henrik Mathias Nilsson | Chief Auditor | 0 companies |
| Mette Pernille Bryngemark | Deputy Board Member | 0 companies |
| Bo Anders Alkestrand | Board of Directors | 0 companies |